GSA CAPITAL PARTNERS LLP - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 119 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 7.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,091
+140.9%
540,250
+103.6%
0.18%
+108.1%
Q1 2023$868
-33.0%
265,372
-19.0%
0.09%
-46.6%
Q4 2022$1,295
-99.9%
327,793
+66.4%
0.16%
+2.5%
Q3 2022$1,182,000
+92.8%
196,977
+106.7%
0.16%
+70.7%
Q2 2022$613,000
-45.5%
95,310
-30.0%
0.09%
-39.1%
Q1 2022$1,124,000136,1050.15%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$220,158,0008.29%
Crestline Management, LP 3,365,624$21,641,0002.82%
Omega Fund Management, LLC 843,750$5,425,0001.73%
Alphabet Inc. 2,812,500$18,084,0000.98%
HARVARD MANAGEMENT CO INC 468,749$3,014,0000.35%
PUBLIC SECTOR PENSION INVESTMENT BOARD 6,400,000$41,152,0000.35%
PFM Health Sciences, LP 952,733$6,126,0000.23%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 156,254$1,005,0000.20%
Viewpoint Capital Management LLC 23,545$151,0000.14%
Artal Group S.A. 400,000$2,572,0000.14%
View complete list of SANA BIOTECHNOLOGY INC shareholders